In the tumor microenvironment, ZFP36 might reduce the growth and invasion of glioma cells by targeting IL-13 mRNA to inhibit the role of PI3K/Akt/mTOR pathways [73-75]. This evidence concerns the gene IL13 and central nervous system cancer.